Cannbiorx Life Sciences Stock Today

ATNFW Stock  USD 0.01  0  22.22%   

Performance

4 of 100

 
Weak
 
Strong
Insignificant

Odds Of Distress

Less than 22

 
High
 
Low
Low
CannBioRx Life is selling for under 0.0084 as of the 28th of November 2024; that is 22.22% down since the beginning of the trading day. The stock's lowest day price was 0.0077. CannBioRx Life has about a 22 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for CannBioRx Life Sciences are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of August 2024 and ending today, the 28th of November 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
27th of June 2017
Category
Healthcare
Classification
Health Care
CannBioRx Life Sciences Corp. discovers and develops pharmaceutical drugs. 180 Life is traded on NASDAQ Exchange in the United States. More on CannBioRx Life Sciences

Moving against CannBioRx Stock

  0.43FDMT 4D Molecular TherapeuticsPairCorr
  0.31INKT Mink TherapeuticsPairCorr

CannBioRx Stock Highlights

CoFounder CoChairmanSir Feldmann
Business ConcentrationBiotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Materials, Materials (View all Sectors)
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Total Current Liabilities8.6 M5.1 M
Way Up
Slightly volatile
Non Current Liabilities Total308.4 K324.6 K
Notably Down
Slightly volatile
Total AssetsM5.3 M
Notably Down
Slightly volatile
Total Current AssetsM3.6 M
Significantly Up
Slightly volatile
CannBioRx Life can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand CannBioRx Life's financial leverage. It provides some insight into what part of CannBioRx Life's total assets is financed by creditors.
Liquidity
CannBioRx Life Sciences has accumulated 1.05 M in total debt. Note, when we think about CannBioRx Life's use of debt, we should always consider it together with its cash and equity.

Begin Period Cash Flow

7.32 Million
CannBioRx Life Sciences (ATNFW) is traded on NASDAQ Exchange in USA. It is located in Building 4, Palo Alto, CA, United States, 94306 and employs 4 people. CannBioRx Life is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 250.78 M. CannBioRx Life Sciences classifies itself under Biotechnology sector and is part of Health Care industry. CannBioRx Life generates negative cash flow from operations
Check CannBioRx Life Probability Of Bankruptcy

CannBioRx Life Historical Income Statement

At this time, CannBioRx Life's Other Operating Expenses is fairly stable compared to the past year. Total Operating Expenses is likely to climb to about 18.7 M in 2024, whereas Selling General Administrative is likely to drop slightly above 7.6 M in 2024. View More Fundamentals

CannBioRx Stock Against Markets

CannBioRx Life Corporate Executives

Elected by the shareholders, the CannBioRx Life's board of directors comprises two types of representatives: CannBioRx Life inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CannBioRx. The board's role is to monitor CannBioRx Life's management team and ensure that shareholders' interests are well served. CannBioRx Life's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CannBioRx Life's outside directors are responsible for providing unbiased perspectives on the board's policies.
Pr NanchahalCoFounder BoardProfile
Pr MDCoFounder BoardProfile
Ozan CFACFO SecretaryProfile

Already Invested in CannBioRx Life Sciences?

The danger of trading CannBioRx Life Sciences is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of CannBioRx Life is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than CannBioRx Life. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile CannBioRx Life Sciences is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.

Additional Tools for CannBioRx Stock Analysis

When running CannBioRx Life's price analysis, check to measure CannBioRx Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CannBioRx Life is operating at the current time. Most of CannBioRx Life's value examination focuses on studying past and present price action to predict the probability of CannBioRx Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CannBioRx Life's price. Additionally, you may evaluate how the addition of CannBioRx Life to your portfolios can decrease your overall portfolio volatility.